Funding supports development and multi-center clinical validation of SondeFlux™, a wearable ultrasound device designed to give physicians objective evidence of upper-esophageal reflux NORTH SALT LAKE, Utah, October 19, 2026 — RefloDx, Inc., a Utah medical device company specializing in noninvasive at-home testing, today announced the completion of its $2 million seed round financing. The financing […]

Data from ongoing study supports the potential clinical utility of whole-genome sequencing-based Precise MRD™ to identify recurrence risk and detect disease earlier following surgery

Sale brings the company’s combined voucher proceeds to $413M, following the approval of two gene therapies within the same number of months.

Participation in NUWATIN 2026 to Support Advancement of Strategic Manufacturing, Technology Transfer, and Industrial Localization Initiatives Under Saudi Vision 2030

Financing Strengthens Balance Sheet and Supports Continued Product Innovation and Commercial Growth

Transaction to benefit patients through expanded access and support Myriad’s strategic priorities

WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response

Additional presentations highlight the design of an ongoing Phase 3 study evaluating tenapanor in chronic idiopathic constipation and the impact of IBS-C symptom burden on quality of life